A
Albert Beckers
Researcher at University of Liège
Publications - 433
Citations - 14960
Albert Beckers is an academic researcher from University of Liège. The author has contributed to research in topics: Acromegaly & Pituitary tumors. The author has an hindex of 60, co-authored 425 publications receiving 13273 citations. Previous affiliations of Albert Beckers include University of the Mediterranean & University of Antwerp.
Papers
More filters
Journal ArticleDOI
High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.
Adrian Daly,Martine Rixhon,Christelle Adam,Anastasia Dempegioti,Maria A. Tichomirowa,Albert Beckers +5 more
TL;DR: The prevalence of pituitary adenomas in the study population (one case in 1064 individuals) was more than 3.5-5 times that previously reported, which may have important implications when prioritizing funding for research and treatment of Pituitary Adenomas.
Journal ArticleDOI
Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.
Bruno Vergès,Françoise Boureille,Pierre Goudet,Arnaud Murat,Albert Beckers,Geneviève Sassolas,Patrick Cougard,Béatrice Chambe,Corinne Montvernay,Alain Calender +9 more
TL;DR: Pituitary adenomas occur in 42% of the cases and are characterized by a larger size and a more aggressive presentation than without MEN1, and are significantly more frequent in women than in men.
Journal ArticleDOI
Pituitary incidentaloma: an endocrine society clinical practice guideline.
Pamela U. Freda,Albert Beckers,Laurence Katznelson,Mark E. Molitch,Victor M. Montori,Kalmon D. Post,Mary Lee Vance +6 more
TL;DR: Practice guidelines for the endocrine evaluation and treatment of pituitary incidentalomas are presented, including indications for surgery.
Journal ArticleDOI
Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.
Johan Verhelst,Roger Abs,Dominique Maiter,Annick Van den Bruel,Mark Vandeweghe,Brigitte Velkeniers,Jean Mockel,G. Lamberigts,Patrick Petrossians,Peter Coremans,Charles Mahler,Achille Stevenaert,Jan Verlooy,Christian Raftopoulos,Albert Beckers +14 more
TL;DR: The high efficacy and tolerability of cabergoline in the treatment of pathological hyperprolactinemia is confirmed, in a large-scale retrospective study, leaving few patients with unacceptable side effects or inadequate clinical response.
Journal ArticleDOI
Cabergoline in the treatment of acromegaly: a study in 64 patients.
Roger Abs,Johan Verhelst,Dominique Maiter,Kristien Van Acker,Frank Nobels,Jean-Luc Coolens,Charles Mahler,Albert Beckers +7 more
TL;DR: The results of this study suggest that cabergoline is an effective, well tolerated therapy that should be considered in the management of acromegaly, especially if the pituitary adenoma cosecretes GH and PRL or if pretreatment plasma IGF-I levels are below 750 micrograms/L.